No trade has been recorded for GSKCH since 30 Jan 2023 — 1,359 days before 20 Oct 2026. The figures on this page are from that session.
▼ −3.88 (−3.13%)
Vol 8.5K · Close · 30 Jan 2023 ● live
On 31 Jan 2023 this ticker became HALEON, Haleon Pakistan Limited. The price history continues on the HALEON page. Open HALEON →
GlaxoSmithKline Consumer Healthcare (GSKCH) last traded at Rs 120.23 on 30 Jan 2023. Its market capitalisation is about Rs 14.1B. GlaxoSmithKline Consumer Healthcare is in the Pharmaceuticals sector.
- Market cap
Market cap
What the whole company costs at today's price.
How it's worked out
Share price multiplied by every share in issue.
How to read it
It is the company's size, not its value. A big number does not mean the price is high against earnings, and a small one does not mean it is low — that is what the ratios below are for.
- Rs 14.1B
- as of 20 Oct 2026
- Price per rupee earned
Price per rupee earned
Rupees you pay for each rupee the company earned last year.
How it's worked out
Share price divided by earnings per share over the last twelve reported months.
How to read it
Lower only means something against something — the same company's history, its sector, or the market. On its own this ratio says very little, and it is blank when a company lost money.
- —
- Dividend yield
Dividend yield
Cash paid out over the last year as a percentage of today's price.
How it's worked out
Dividends per share over twelve months divided by the share price.
How to read it
A very high yield is often a warning, not a gift: it usually means the price fell. Check the payout ratio next to see whether earnings actually cover it.
- —
- Avg volume (30d)
Average volume
Shares changing hands on a typical day.
How it's worked out
The mean daily volume over thirty sessions.
How to read it
Shares, not rupees — a million shares of a Rs 3 stock is a small market. "Traded per session" is the version in money.
- 13.6K
—
- 1W
- —
- 1M
- 0.00%
- 3M
- 0.00%
- 6M
- —
- YTD
- —
- 1Y
- 0.00%
- Free float
Free float
The shares that can actually be bought and sold.
How it's worked out
Total shares minus the blocks held by sponsors, the government and other locked-in holders, as the exchange reports them.
How to read it
The float, not the market cap, is what sets how easily a real position can be built or unwound.
- 15.6M
- 13.3% of shares
- Shares outstanding
- 117M
- Day range
- —
- prev close 124.11
- Shariah
- —
No price history available for this symbol yet.
GlaxoSmithKline Consumer Healthcare filings and reports
20 documents GlaxoSmithKline Consumer Healthcare has published — annual reports, quarterly accounts and briefing decks. PSX filings are marked PSX; the rest come from the company’s own investor relations page. Links open the original PDF at the source.
SuperX keeps 4 annual reports for this company and has read none of them yet. Until one is read, this page has no balance sheet for GSKCH — no return on equity, no book value, no gearing. The reports are linked below and the figures are in them.
Annual reports · 4
Quarterly accounts · 16
- Financial Results for the Quarter Ended 30 September 2022 PSX
- Quarterly report 2022 PSX
- Financial Results for the Quarter Ended 30 June 2022 PSX
- Quarterly report 2022 PSX
- Quarterly report 2022 PSX
- Quarterly report 2021 Company
- Quarterly report 2021 Company
- Quarterly report 2021 Company
and 8 more
GSKCH’s dated record
The exchange’s own record and ours: ex-dividends, book closures, results, every session move of 3% or more with the reason written out, the notices that move a price, and the news about GlaxoSmithKline Consumer Healthcare. Dates that have not happened are kept apart from dates that have, and each one says whether it was announced or projected.
The last 90 days · 1
-
15 Aug 2026
- Results half_year results due 2026-08-15 – 2026-09-02 projected A window from past filings, not a date the company gave.
Earlier · 21
Notice 20 notices, 1 Mar 2021 to 5 Dec 2022 open
- 5 Dec 2022 board meeting Results of the Board of Directors Meeting Other than Financial Results
- 25 Nov 2022 board meeting Notice of Board Meeting Other Than Financial Results
- 21 Oct 2022 financial results Financial Results for the Quarter Ended 30 September 2022
- 13 Oct 2022 board meeting Notice of Board of Directors Meeting - (Q3-2022)
- 23 Aug 2022 financial results Financial Results for the Quarter Ended 30 June 2022
- 15 Aug 2022 board meeting Notice of Board of Directors Meeting - (Q2-2022)
- 25 Apr 2022 financial results Financial Results for the Quarter Ended 31 March 2022
- 22 Apr 2022 board meeting Board Meeting in Progress
- 14 Apr 2022 board meeting Notice of Board of Directors Meeting - (Q1-2022)
- 9 Feb 2022 financial results Financial Results for the Year Ended 31 December 2021
- 3 Feb 2022 board meeting Board of Directors Meeting - (Q4-2021)
- 2 Feb 2022 board meeting 23rd Board of Directors Meeting REVOKED
- 26 Oct 2021 financial results Financial Results for the Quarter Ended 30 September 2021
- 15 Oct 2021 board meeting Notice of Board Meeting (Q3-2021)
- 24 Aug 2021 financial results Financial Result for the Quarter Ended 2021-06-30
- 13 Aug 2021 board meeting Notice of Board Meeting (Q2-2021)
- 23 Apr 2021 financial results Financial Results for the Quarter Ended 2021-03-31
- 16 Apr 2021 board meeting Notice of Board Meeting (Q1-2021)
- 5 Mar 2021 financial results Financial Results for the Year Ended December 31, 2020
- 1 Mar 2021 board meeting Board Meeting - Q4-2020
Results 1 results filings, 21 Oct 2022 to 21 Oct 2022 open
- 21 Oct 2022 nine_months results (2022-09-30)
SuperX holds 61 dated records for GSKCH and this page lists 22. Every ex-dividend, book closure, results filing and ticker change is listed. The notices are cut to the most recent of each.
What SuperX wrote about GSKCH
SuperX writes a nightly note for the 100 companies in the KSE-100. This is not one of them. GlaxoSmithKline Consumer Healthcare is not one of them, so this page carries no note.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on March 31, 2015 principally to effect the demerger of consumer healthcare business of GlaxoSmithKline Pakistan Limited (GSK Pakistan). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is Haleon plc. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.
- Sector
- Pharmaceuticals
- Head office
- Sandoz Nagar, Petaro Road, Jamshoro, Sindh.
- Auditor
- Yousuf Adil, Chartered Accountants
- Share registrar
- CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
- Fiscal year end
- December
What are GSKCH’s sales, profit and earnings per share?
Annual figures from PSX filings. Money in PKR (converted from thousands); EPS in rupees per share.
| FY (December) | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Sales | Rs 24.2B | Rs 19.8B | Rs 16.3B | Rs 14.9B |
| Profit after Taxation | Rs 2.1B | Rs 1.3B | Rs 1.3B | Rs 1.1B |
| EPS | Rs 18.23 | Rs 10.78 | Rs 10.74 | Rs 9.18 |
| EPS Growth | +69.1% | +0.4% | +17.0% | +24.2% |
| Gross Profit Margin | 27.4% | 26.9% | 30.6% | 29.2% |
| Net Profit Margin | 8.8% | 6.4% | 7.7% | 7.2% |
GSKCH dividends and corporate actions
PSX quotes payouts as a % of the Rs 10 face value — 25% = Rs 2.50 per share. Unconfirmed ex-dates are marked “expected”.
| Type | % of face | Per share | Ex-date | Book closure | Qualify by |
|---|---|---|---|---|---|
| No dividends or corporate actions on record for GSKCH. | |||||
No matches.
Brokers’ 12-month price targets for GSKCH, not SuperX’s
Collected from sell-side research notes. SuperX publishes no price target and no rating of its own.
No analyst coverage on record for GSKCH. 48 of the companies on this site carry any, and 48 of those 48 carry a buy-family label.
GSKCH share price: quick answers
What is the GSKCH share price?
GlaxoSmithKline Consumer Healthcare (GSKCH) last traded at Rs 120.23 on 30 Jan 2023.
What is GSKCH's dividend yield?
SuperX's PSX data does not show a trailing dividend yield for GlaxoSmithKline Consumer Healthcare (GSKCH) as of 30 Jan 2023. Check the dividend history table on this page for declared payouts.
How much does GSKCH cost for each rupee it earns?
SuperX cannot price GSKCH against its earnings as of 30 Jan 2023, because the trailing twelve months show no profit to divide by — the earnings are negative or not yet reported. See the financials table for reported earnings per share.
Is GSKCH Shariah compliant?
SuperX's PSX data has no Shariah screening status for GSKCH as of 30 Jan 2023.
What happened to GSKCH?
On 31 Jan 2023 this ticker became HALEON, Haleon Pakistan Limited. The price history continues on the HALEON page.
Other Pharmaceuticals stocks on PSX
Other companies in the same PSX sector, including its largest.
| Symbol | Company | Price | Chg % | Mkt cap | Price/earnings |
|---|---|---|---|---|---|
| HALEON | Haleon Pakistan Limited | 670.90 | −0.95% | Rs 78.5B | 11.9× |
| HINOON | Highnoon Laboratories Limited | 937.43 | −0.09% | Rs 49.7B | 11.9× |
| HPL | Hoechst Pakistan Limited | 4,056.91 | +0.03% | Rs 39.1B | 10.4× |
| GLAXO | GlaxoSmithKline Pakistan Limited | 315.05 | +0.34% | Rs 100B | 9.6× |
| ABOT | Abbott Laboratories (Pakistan) Limited | 935.61 | −1.28% | Rs 91.6B | 10.7× |
| SEARL | The Searle Company Limited | 76.65 | +0.43% | Rs 45.1B | 11.3× |
No matches.
Guides for GSKCH
Plain explanations of the figures on this page.
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .
Track GSKCH in SuperX
Trade logging, price alerts and smart-money flows for PSX investors. Join the waitlist and we email once, when it is ready.
GET EARLY ACCESS — FREE →